Panoral®
Capsules for oral use
Panoral®
| dosage/strength | dosage form | pack size | pharmaceutical registration number | SmPC | |
|---|---|---|---|---|---|
| 500 mg | capsules for oral use | 10 hard-capsules | N1 | 02070996 |  |
| capsules for oral use | 20 hard-capsules | N2 | 02078354 | ||
| capsules for oral use | 30 hard-capsules | N3 | 00832373 |
Active substance:
Cefaclor Monohydrate
Pharmacotherapeutic group:
Cefaclor is a beta-lactam antibiotic, an cephalosporin.
ATC code: J01DC04
Mechanism of action:
The mechanism of action of Cefaclor is based on the inhibition of bacterial cell wall synthesis (in the growth phase) by blocking the penicillin-binding proteins (PBPs) such as transpeptidases. This results in a bactericidal effect.
Therapeutic indications:
For the treatment of acute or chronic infections of different severity caused by pathogens that are sensitive to cefaclor and accessible to oral therapy.
This includes:
- Upper and lower respiratory tract infections
- Infections of ear, nose and throat, such as otitis media, sinusitis, tonsillitis, pharyngitis
- Renal and urinary tract infections
- Skin and soft tissue infections
- Gonorrhea